Hepatitis C. New guidelines on precautions, follow-up. NLM AIDSLINE Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Hepatitis C. New guidelines on precautions, follow-up.

OR Manager. 1997 Sep;13(9):38-9. Unique Identifier : AIDSLINE MED/97456124


Abstract: An OR team has a greater chance of operating on a patient infected with hepatitis C than on a patient with HIV or hepatitis B. Many patients with HCV aren't critically ill, and the team may not know a patient is infected. HCV is more common than many think--an estimated 3.5 million people in the US are infected. The consequences are grave. For most, infection is lifelong. At least 85% become chronically infected. Chronically infected individuals are at risk for cirrhosis and liver cancer. Unfortunately, not much can be done to prevent transmission. There is no vaccine and not much in the way of treatment. In recent weeks, the Centers for Disease Control and Prevention CDC) and professional societies have tried to address workers' concerns with new recommendations that, although they don't provide easy answers, offer added guidance.
Keywords: *Disease Transmission, Patient-to-Professional/PREVENTION & CONTROL *Hepatitis C/PREVENTION & CONTROL *Infection Control/STANDARDS *Operating Rooms/STANDARDS *Personnel, Hospital/STANDARDSKWDdiseasetransmission,patient-to-professional/prevention&controlKWDhepatitisc/prevention&controlKWDinfectioncontrol/standardsKWDoperatingrooms/standardsKWDpersonnel,hospital/standards
971230
M97C1609

Copyright © 1997 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .